COMMUNIQUÉS West-GlobeNewswire

CMS Rating for Amedisys Home Health Rises to 32 Percent Above the National Average

06/06/2018 - 13:00

BATON ROUGE, La., June 06, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home healthcare, hospice and personal care companies, received an average rating of 4.30 Stars out of a [...]

Dr. Sherrell J. Aston is One of the First to Offer New Groundbreaking EmbraceRF Procedure

06/06/2018 - 13:00

NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- Dr. Sherrell J. Aston introduces EmbraceRF, a new facial contouring technique that addresses a treatment gap in current modalities offered to patients. EmbraceRF provides the [...]

T2 Biosystems Reports Granting of Inducement Awards

06/06/2018 - 13:00

LEXINGTON, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]

Acasti Pharma to Present at the XVIII(th) International Symposium on Atherosclerosis

06/06/2018 - 13:00

LAVAL, Québec, June 06, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ:ACST) (TSX-V:ACST) (the “ Company ” or “ Acasti Pharma ”), a biopharmaceutical innovator focused on the research, development and [...]

Cannabis Wheaton Income Corp. Announces Proposed Change of Name

06/06/2018 - 13:00

VANCOUVER, British Columbia, June 06, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (" Cannabis Wheaton " or the " Company ") is pleased to announce that the Company intends to change its name to " [...]

Intra-Cellular Therapies Initiates Rolling Submission of New Drug Application for Lumateperone for Treatment of Schizophrenia

06/06/2018 - 13:00

NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

BeiGene to Present at the Goldman Sachs 39th Annual Global Healthcare Conference

06/06/2018 - 13:00

CAMBRIDGE, Mass., and BEIJING, China, June 06, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted [...]

The Alliance for Regenerative Medicine Launches Foundation to Promote Understanding and Acceptance of Potentially Curative Cell and Gene Therapies

06/06/2018 - 13:00

Non-profit will educate, engage, and empower patients, caregivers, scientists, and industry leaders WASHINGTON, DC, June 06, 2018 (GLOBE NEWSWIRE) -- As part of its ongoing efforts to accelerate patient access to safe, [...]

BioCorRx Raises $1.1 Million at Premium to Market

06/06/2018 - 13:00

ANAHEIM, CA, June 06, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced the Company [...]

AxoGen, Inc. to Present at Upcoming Investor Conferences

06/06/2018 - 13:00

William Blair 38 th Annual Growth Stock Conference, June 14 JMP Securities Life Sciences Conference, June 20 ALACHUA, Fla., June 06, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and [...]

InMode Aesthetic Solutions Launches A New Concept for Subdermal Adipose-Remodeling of the Face, EmbraceRF and Morpheus8

06/06/2018 - 12:45

LAKE FOREST, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- InMode Aesthetic Solutions, the leader in cutting edge aesthetic medicine and technology solutions introduces EmbraceRF, a new facial contouring technique that [...]

Nightstar Therapeutics Reports First Quarter 2018 Financial Results and Acceleration of Preliminary NSR-RPGR Readout to Third Quarter 2018

06/06/2018 - 12:35

Preliminary data from dose escalation study in the Phase 1/2 XIRIUS trial for X-Linked Retinitis Pigmentosa expected ahead of schedule in Q3 2018 Dose expansion study in the XIRIUS trial expected to begin enrollment in [...]

RavenQuest Announces Letter of Intent to Purchase Western Agripharma Ltd.

06/06/2018 - 12:00

VANCOUVER, British Columbia, June 06, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (the “ Company ” or “ RavenQuest ”) is pleased to announce that it has entered into a binding letter of intent with Western [...]

Calithera to Present at the Jefferies and JMP Securities Healthcare Conferences in June

06/06/2018 - 11:01

SOUTH SAN FRANCISCO, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, announced today [...]

Wellcome Sanger Institute Sequences Reference Genomes of 3,000 Dangerous Bacteria

06/06/2018 - 10:00

Gonorrhoea, Deadly Plague and Dysentery Among Collection of Bacterial Genomes Now Publicly Available Through Collaboration with Pacific Biosciences HINXTON, United Kingdom and MENLO PARK, Calif., June 06, 2018 (GLOBE [...]

ESPERITE NV (ESP) LAUNCHS NEW AGAATA Dx, DIAGNOSTIC SYSTEM WITH MACHINE LEARNING CAPABILITIES FOR GENETIC CLINICAL LABORATORIES.

06/06/2018 - 08:27

AGAATA delivers clinical reports in the fields of Reproductive Health, Oncology and Inherited Diseases. Amsterdam, The Netherlands -6 th June 2018 AGAATA innovates a fully integrated and certified CE-IVD Diagnostic [...]

Shire plc : Rule 2.9 announcement

06/06/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 6 June 2018 Shire [...]

Axovant Licenses Investigational Gene Therapy for Parkinson’s Disease from Oxford BioMedica and Announces Key Leadership Team Addition

06/06/2018 - 08:00

Exclusive worldwide license to lentiviral vector gene therapy constitutes the first transaction of Axovant’s 2018 pipeline expansion Fraser Wright, Co-Founder and former Chief Technology Officer of Spark Therapeutics, [...]

NICOX : accord de collaboration de recherche avec Ironwood Pharmaceuticals pour de nouvelles thérapeutiques ophtalmiques

06/06/2018 - 07:31

Communiqué de presse Nicox : accord de collaboration de recherche avec Ironwood Pharmaceuticals pour de nouvelles thérapeutiques ophtalmiques ............................................. 6 juin 2018 - diffusion à 7h30 [...]